# Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

> **NCT01447758** · PHASE1 · TERMINATED · sponsor: **LEO Pharma** · enrollment: 58 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** LEO 29102
- **DRUG:** LEO 29102 Cream Vehicle

## Key facts

- **NCT ID:** NCT01447758
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447758, "Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01447758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*